TRANSLATE

Welcome to Our Parkinson's Place


I copy news articles pertaining to research, news and information for Parkinson's disease, Dementia, the Brain, Depression and Parkinson's with Dystonia. I also post about Fundraising for Parkinson's disease and events. I try to be up-to-date as possible. I have Parkinson's
diseases as well and thought it would be nice to have a place where
updated news is in one place. That is why I began this blog.
I am not responsible for it's contents, I am just a copier of information searched on the computer. Please understand the copies are just that, copies and at times, I am unable to enlarge the wording or keep it uniformed as I wish. This is for you to read and to always keep an open mind.
Please discuss this with your doctor, should you have any questions, or concerns. Never do anything without talking to your doctor. I do not make any money from this website. I volunteer my time to help all of us to be informed. Please No advertisers, and No Information about Herbal treatments. This is a free site for all.
Thank you.


Tuesday, May 2, 2017

New NIST data to aid production and storage of 'fascinating' medication

May 2, 2017
NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY (NIST)

NIST chemists have published the first data on the thermodynamic properties of amantadine hydrochloride, used for many years as the active pharmaceutical ingredient for antiviral and anti-parkinsonian medications. The new information can help optimize production and storage conditions of this important compound. Its structure in the gas phase was obtained by quantum chemistry methods. In the molecular structure, C is carbon, H is hydrogen, N is nitrogen, and Cl is chlorine. CREDIT: Bazyleva/NIST


Amantadine hydrochloride may be the most common medication you've never heard of. This compound has been around for decades as the basis for antiviral and other medications, from flu therapy to treatments for brain disorders such as Parkinson's disease and the fatigue associated with multiple sclerosis.
And yet, this compound has long been a bit of an enigma because of missing information on its properties. Now, chemists at the National Institute of Standards and Technology (NIST) and collaborators have published the very first data on this important chemical's thermodynamic properties, including data on how it responds to heat and changes from a solid into a gas.
Such data are valuable to the chemical and pharmaceutical industries for getting the highest production yields and shelf life for the medication.
"Our research results are not directly related to the medical application of this multifunctional drug, although I am really fascinated by the range of its pharmacological activity," NIST research chemist Ala Bazyleva said.
"We studied its thermodynamic properties and decomposition," Bazyleva said. "It is surprising, given the long history of amantadine-based drugs, that there is almost no information like this in the literature for many of them. Chemical engineers often have to rely on estimates and predictions based on similar compounds. Collating this information and developing these types of recommendations is at the core of what our group at NIST does."
Amantadine hydrochloride belongs to a diamondoid class, a family of compounds whose structure is based on a cage of carbon atoms similar to diamond. Amantadine has a single carbon cage with a nitrogen atom attached on one side. Nonmedical studies have focused on the solid form of amantadine hydrochloride because it was expected to form disordered, or plastic, crystals, as many diamondoids do. Turns out, amantadine hydrochloride does not.
Bazyleva began studying amantadine hydrochloride years ago while in Belarus working on her doctoral dissertation, and continued the effort during her postdoctoral studies in Germany and Canada. But progress was slow, partly because adamantine hydrochloride changes from a solid directly into a gas (a process called sublimation) and simultaneously falls apart, or decomposes. She needed a model explaining this complex process, one that incorporates detailed, high-level calculations of quantum chemistry. She finally got access to this computational capability after she began working with the Thermodynamics Research Center (TRC) Group at NIST in Boulder several years ago.
"NIST was fundamental in facilitating the modeling component," Bazyleva said. "In particular, the unique combination of facilities, software and expertise in quantum chemical computations allowed us to apply high-level calculations to get insight into the structure and stability of the drug in the gas phase."
While the compound behaves like it is ionic (composed of positively and negatively charged pieces, though neutral overall) in the solid crystal form and when dissolved in a liquid, quantum chemistry calculations revealed that it decomposes into two neutral compounds in the gas phase.
###
The data were generated by NIST's TRC, which for more than 70 years has been producing chemical data for scientific research and industrial process design.
Co-authors are from the Belarusian State University in Belarus; the University of Rostock in Germany; and the University of Alberta in Canada.
Paper: A. Bazyleva, A.V. Blokhin, D.H. Zaitsau, G.J. Kabo, E. Paulechka, A.F. Kazakov and J.M. Shaw. Thermodynamics of the antiviral and antiparkinsonian drug amantadine hydrochloride: condensed state properties and decomposition. Journal of Chemical and Engineering Data. Published online May 1. DOI: 10.1021/acs.jced.7b00107
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

https://www.eurekalert.org/pub_releases/2017-05/nios-nnd050217.php

No comments:

Post a Comment